Free tool

Oncology stocks

We cover 10 companies grouped under the Oncology theme. The median market value in the group is $244.95M. Across the group, the median move over the past trading day is −1.84%. Price change over the past year runs from −47.9% to +906.8% across the middle 80 percent of the group, with a median of −0.5%.

Other lists in this group

Table

10 of 319 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y returnNext report
NANO.PANanobiotix S.A.$2.12BMid cap+341.09%Sep 29, 2026
0QAV.LNanobiotix S.A.$671.98MSmall cap+346.30%Sep 29, 2026
PRTC.LPureTech Health plc$402.61MSmall cap−11.34%Aug 27, 2026
IDD.DEInnate Pharma S.A.$247.30MSmall cap−2.52%Sep 17, 2026
IPH.PAInnate Pharma S.A.$244.95MSmall cap+1.84%Sep 17, 2026
BINV.STBioInvent International AB (publ)$169.15MSmall cap−24.30%Aug 27, 2026
0RU5.LOncoinvent ASA$128.23MSmall cap+5951.72%Aug 27, 2026
OSE.PAOSE Immunotherapeutics SA$88.77MMicro cap−47.82%Sep 28, 2026
0RAD.LOSE Immunotherapeutics SA$51.87MMicro cap−48.92%Sep 28, 2026
0VQ.DEPureTech Health plc+1.50%Aug 27, 2026

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse